Savaysa
Payments companies reported to CMS as associated with Savaysa. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Savaysa, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Savaysa
These are the largest totals companies reported as associated with Savaysa. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Robert Giugliano | Boston, MA | Cardiovascular Disease | $46,747.00 |
| George Dangas | New York, NY | Interventional Cardiology | $41,703.70 |
| Alex Spyropoulos | Rochester, NY | Hematology & Oncology | $28,005.74 |
| Iraklis Pipinos | Omaha, NE | Vascular Surgery | $23,599.18 |
| Charles Gibson | Boston, MA | Interventional Cardiology | $13,585.00 |
| Christian Ruff | Boston, MA | Cardiovascular Disease | $2,655.00 |
| Jerrold Levy | Durham, NC | Anesthesiology | $2,250.00 |
| Mandeep Mehra | Boston, MA | Cardiovascular Disease | $353.88 |
| Michael Gibson | Orange, CA | Cardiovascular Disease | $40.00 |
Prescribed Savaysa?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.